Optimizing Patient Referral Pathways for Radioligand Therapies
Oncology care coordination is a complex process where patients must engage with various healthcare teams across specialties to treat their condition. The patient referral pathway is an important step within this process, requiring efficient and timely management. Many patients often face barriers to accessing necessary care during this process due to the numerous and at times unclear steps involved, causing delays in treatment initiation.
These issues are exacerbated for novel treatments as they often require a new referral paradigm. As novel oncology treatments such as radioligand therapies enter already constrained healthcare systems, clear, efficient, and scalable patient referral pathways will be important in ensuring timely treatment for patients.
This webinar will include external experts as well as Institute staff. This webinar is ideal for:
- Providers
- Patient advocates
- Healthcare policymakers
- Hospital administrators
- Pharma
- And all areas of the life sciences industry
Confirmed panelists to date:
Elena Castro, MD, Ph.D.
Hospital Universitario 12 de Octubre
Paola Erba MD, Ph.D.
European Association of Nuclear Medicine (EANM)
Francesco De Lorenzo, MD
Italian Federation and Association of Volunteers in Oncology (FAVO)
Anne-Laure Giraudet, MD, Ph.D.
Centre Léon Bérard
Boris Hadaschik, MD
University Hospital Essen
Moderator: Murray Aitken
Executive Director
IQVIA Institute for Human Data Science
Agenda
- Welcome and introductions
- Moderated discussion among panelists
- State of RLT innovation and impact on cancer care
- RLT patient referral pathways - bottlenecks and best practices across countries
- Healthcare policies and processes needed to enhance referral process to ensure equitable and timely access to RLTs
- Q&A
- Concluding thoughts